References
- Kovac MK, Lalic-Cosic SZ, Dmitrovic JM, et al. Thrombin generation, D-dimer and protein S in uncomplicated pregnancy. Clin Chem Lab Med. 2015;53(12):1975–1979.
- Kolettis D, Craigo S. Thromboprophylaxis in pregnancy. Obstet Gynecol Clin North Am. 2018;45(2):389–402.
- Zhao Z, Zhou Q, Li X. Missed opportunities for venous thromboembolism prophylaxis during pregnancy and the postpartum period: evidence from mainland China in 2019. BMC Pregnancy Childbirth. 2021;21(1):400–406.
- Duarte RCF, Ferreira CN, Rios DRA, et al. Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations. Rev Bras Hematol Hemoter. 2017;39(3):259–265.
- Lipets EN, Ataullakhanov FI. Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk. Thromb J. 2015;13(1):4–18.
- Dong F, Wang L, Wang C. Thrombin Generation in chinese pregnant women and the effect of insulin use on thrombin generation in patients with GDM. Clin Appl Thromb Hemost. 2019;25:1076029619863492–1076029619863496.
- Joly BS, Sudrie-Arnaud B, Barbay V, et al. Thrombin generation test as a marker for high risk venous thrombosis pregnancies. J Thromb Thrombolysis. 2018;45(1):114–121.
- Patel JP, Patel RK, Roberts LN, et al. Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium. BMC Preg Childbirth. 2014;14:384–393.
- Bagot CN, Leishman E, Onyiaodike CC, et al. Normal pregnancy is associated with an increase in thrombin generation from the very early stages of the first trimester. Thromb Res. 2017;157:49–54.
- Tripodi A. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin. Thromb Haemost. 2017;117(5):830–836.
- Wan J, Vadaq N, Konings J, et al. Kallikrein augments the anticoagulant function of the protein C system in thrombin generation. J Thromb Haemost. 2022;20(1):48–57.
- Efthymiou M, Lane PJ, Isenberg D, et al. Comparison of acquired activated protein C resistance, using the CAT and ST-Genesia((R)) analysers and three thrombin generation methods, in APS and SLE patients. JCM. 2021;11(1):69–82.
- Dargaud Y, Trzeciak MC, Bordet JC, et al. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost. 2006;96(5):562–567.
- Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium–a register-based case-control study. Am J Obstet Gynecol. 2008;198(2)233.e1-7.
- Won HS, Kim DY, Yang MS, et al. Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy. Korean Circ J. 2011;41(1):23–27.
- Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317–3359.
- Benhalima K, Van Crombrugge P, Hanssens M, et al. Gestational diabetes: overview of the new consensus screening strategy and diagnostic criteria. Acta Clin Belg. 2012;67(4):255–261.
- Horowitz GL, Altaie S, Boyd JC, et al. Defining establishing and verifying reference intervals in the clinical laboratory; approved guideline. 3rd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2010.
- van Veen JJ, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol. 2008;142(6):889–903.
- Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem. 2016;62(5):699–707.
- Hemker HC, Giesen P, AlDieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32(5–6):249–253.
- Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33(1):4–15.
- Lisman T, Adelmeijer J. Preanalytical variables affect thrombomodulin-modified thrombin generation in healthy volunteers. Thromb Res. 2020;194:237–239.
- Tripodi A, Martinelli I, Chantarangkul V, et al. Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban. Int J Hematol. 2016;103(2):165–172.
- Dargaud Y, Hierso S, Rugeri L, et al. Endogenous thrombin potential, prothrombin fragment 1 + 2 and D-dimers during pregnancy. Thromb Haemost. 2010;103(2):469–471.
- Majumder R, Nguyen T. Protein S: function, regulation, and clinical perspectives. Curr Opin Hematol. 2021;28(5):339–344.
- Cerneca F, Ricci G, Simeone R, et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol. 1997;73(1):31–36.
- Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114(5–6):409–414.
- Gorar S, Alioglu B, Ademoglu E, et al. Is There a tendency for thrombosis in gestational diabetes mellitus? J Lab Physicians. 2016;8(2):101–105.
- Stegenga ME, van der Crabben SN, Levi M, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55(6):1807–1812.